Science & Research
-
Pregnancy and Prescription Medication Use Symposium
Objectives:
- Showcase completed PK and PD Pregnancy studies funded by OWH
- Provide opportunities for FDA scientists to network in order to collaboratively advance the Agency’s public health mission
- Increase awareness regarding the use of prescription medications used during pregnancy and the need for ongoing studies to improve pregnancy labeling
Webcast of the symposium
-
Speaker Presentations
- Clinical Therapeutics in Obstetrics, Don Mattison, MD (PPTX - 2.8MB)
Use of ACE Inhibitors in Pregnant Women and the Risk of Congenital Heart Defects, De-Kun Li, MD, PhD (PPT - 1.7MB)Clinical Pharmacology of Drugs in Pregnancy, Mary Hebert, PharmD (PPT - 16.5MB)Pregnant Women and Clinical Trials: Scientific, Regulatory, and Ethical Considerations, Karen Feibus, MD and Sara Goldkind, MD (PPT - 271KB)The Pharmacokinetics of Antidepressants Across Pregnancy: The MADRE Study, Marlene Freeman, MD (PPT - 4.6MB)Labetalol Pharmacokinetics in Hypertension During Pregnancy, James Fisher, PharmD (PPTX - 392KB)Azithromycin Pharmacokinetics in Pregnancy, James Fisher, PharmD (PPTX - 264KB)Using Automated Databases to Assess Fetal Effects of Maternal Medication Use, William Cooper, MD, MPH (PPT - 1.5MB)Round Table Discussion, Emmanuel Fadiran, RPh, PhD (PPT - 191KB)
-
-
-